Orofacial Pain: When How and What to Treat is organized by Herman Ostrow School of Dentistry of University of Southern California (USC) and will be held on Oct 19, 2018 at Herman Ostrow School of Dentistry of USC, Los Angeles, California, United States of America.
The target audience for this medical event is dentists and other health care professionals dealing with chronic pain conditions and dysfunction of the orofacial region. It will focus on treatment strategies and pharmacological management.This CME Conference has been approved for a maximum of 7 Continuing Education Credits.
Conference Description :
This course focuses on Chronic Orofacial Pain (OFP) and headaches (e.g. Neuropathic Pain, Neurovascular Pain, Neuralgia, Neuritis, and Neuroma). It reviews underlying mechanisms of pain induction, nerve injury and repair, sensitization and spontaneous ectopic pain generation. Lectures include an explanation of how various analgesic blocks and sensory testing procedures, in combination with historical information, produce a differential diagnosis of neurogenic and headache pain. Lectures will also focus on the appropriate pharmacologic, behavioral, surgical, and physical medicine manages- ment procedures for these conditions. Finally, real patient cases will be presented with the goal of helping the attendee become more comfortable in diagnosing and treating OFP disorders and providing a new understanding of chronic pain.
This course will cover the medications used to treat chronic orofacial pain, including neurogenic, musculoskeletal, headache and uncommon pain disorders. To be able to treat patients with these problems, dentists must understand the underlying mechanisms of pain transmission, nerve injury and repair, sensitization, sympathetic pain maintenance and spontaneous ectopic pain generation. Dentists must be able to perform various analgesic blocks and sensory testing procedures as well as understand how these procedures combined with historical information allow for a differential etiologic-based diagnosis to be made. This course is divided into lecture presentations in the morning, demonstrations and workshops in the afternoon and specific case discussions at the end of the day.
Conference Topics :
• Chronic orofacial pains (neuralgias, neuromas, and neuropathies of the trigeminal nerve).
• Headache disorders which mimic Temporomandibular Disorder (TMD) and cause orofacial pain.
• Neurology for the novice.
• New medications used for pain.
• Examination methods for chronic pain.
• Issues of California drug law, the DEA/DOJ and using off-label prescriptions.
• Advances in pharmacy-genetics as a way of predicting drug to drug interactions and adverse drugs reactions.
• Treatment of chronic pain using behavioral, physical and surgical therapies.
• Use of an electronic medical record and automated computer-patient interface for medical documentation.
• PDA-based drug program.
• Pain diary and pain treatment agreements in dental practice.
• Know the neuroanatomy, neurophysiology, and pathobiology of the trigeminal nociceptive system.
• Understand neurogenous and neurovascular diseases.
• Be able to conduct a differential diagnosis of neurogenic and headache disorders.
• Know the current therapies used for these problems.
• Understand how neurovascular headaches can convert from episodic to chronic.
• Be familiar with the latest medications used for managing both neurovascular and neurogenic pain.
• Know how to make stents, perform intramuscular injections, and conduct a myofascial examination.
• Medications used in dentistry and the Law: What can be prescribed and what not?
• 10 Top medications used in an OFP Specific Treatment Center.
• Metabolism of medications including liver enzymes systems.
• The various chronic pain diseases that appear in the orofacial region.
• Non-pharmacologic therapies for OFP.
• Pharmacogenetics and medication efficacy.
• Current approaches for treating non-malignant chronic orofacial pain.
• How to conduct a myofascial examination.
• How to perform therapeutic injections (trigger point, botulinum toxin and corticosteroid).